晨光生物
(300138)
| 流通市值：52.30亿 | | | 总市值：63.43亿 |
| 流通股本：3.98亿 | | | 总股本：4.83亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 5,031,137,226.16 | 3,159,134,012.82 | 1,628,953,634.09 | 6,559,043,728.38 |
| 营业总成本 | 4,738,990,013.21 | 2,968,152,280.45 | 1,521,636,644.31 | 6,178,716,674.03 |
| 其他经营收益 | | | | |
| 营业利润 | 326,012,878.68 | 210,867,040.29 | 113,658,573.3 | 436,359,595.5 |
| 利润总额 | 324,882,544.55 | 212,199,574.06 | 113,881,058.25 | 437,869,987.46 |
| 净利润 | 278,190,898.57 | 184,286,276.37 | 98,400,487.74 | 374,875,475.85 |
| 每股收益 | | | | |
| 其他综合收益 | -29,792,014.34 | -22,763,435.29 | -13,913,355.02 | -26,494,256.96 |
| 综合收益总额 | 248,398,884.23 | 161,522,841.08 | 84,487,132.72 | 348,381,218.89 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 6,757,351,754.2 | 7,540,569,111.64 | 9,031,813,699.53 | 7,431,240,858.44 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,131,241,914.72 | 2,075,571,012.07 | 2,060,315,939.45 | 2,073,197,884.2 |
| 资产总计 | 8,888,593,668.92 | 9,616,140,123.71 | 11,092,129,638.98 | 9,504,438,742.64 |
| 流动负债: | | | | |
| 流动负债合计 | 5,117,630,994.11 | 5,885,034,612.25 | 7,292,676,052.05 | 5,782,438,648.52 |
| 非流动负债: | | | | |
| 非流动负债合计 | 291,806,259.19 | 275,525,765.73 | 275,979,521.64 | 283,013,161.57 |
| 负债合计 | 5,409,437,253.3 | 6,160,560,377.98 | 7,568,655,573.69 | 6,065,451,810.09 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 3,421,451,691.04 | 3,399,950,885.03 | 3,471,922,228.04 | 3,389,113,999.02 |
| 股东权益合计 | 3,479,156,415.62 | 3,455,579,745.73 | 3,523,474,065.29 | 3,438,986,932.55 |
| 负债和股东权益合计 | 8,888,593,668.92 | 9,616,140,123.71 | 11,092,129,638.98 | 9,504,438,742.64 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 5,852,841,098.98 | 3,527,937,008.62 | 1,904,376,825.31 | 7,800,072,160.47 |
| 经营活动现金流出小计 | 3,498,357,010.54 | 2,309,954,769.56 | 1,627,516,146.63 | 7,587,165,191.48 |
| 经营活动产生的现金流量净额 | 2,354,484,088.44 | 1,217,982,239.06 | 276,860,678.68 | 212,906,968.99 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 3,020,975,427.93 | 1,350,209,160.08 | 664,848,754.68 | 894,220,433.33 |
| 投资活动现金流出小计 | 3,227,710,895.19 | 2,356,752,406.32 | 1,906,530,673.25 | 902,718,389.48 |
| 投资活动产生的现金流量净额 | -206,735,467.26 | -1,006,543,246.24 | -1,241,681,918.57 | -8,497,956.15 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 3,717,788,345.44 | 2,753,792,345.44 | 2,114,997,315.44 | 5,996,434,035.9 |
| 筹资活动现金流出小计 | 4,732,687,760.07 | 2,795,439,913.54 | 712,689,123.94 | 5,926,981,853.67 |
| 筹资活动产生的现金流量净额 | -1,014,899,414.63 | -41,647,568.1 | 1,402,308,191.5 | 69,452,182.23 |
| 汇率变动对现金及现金等价物的影响 | 2,106,860.87 | 2,766,664.79 | 1,217,453.22 | -3,622,724.59 |
| 现金及现金等价物净增加额 | 1,134,956,067.42 | 172,558,089.51 | 438,704,404.83 | 270,238,470.48 |
| 期末现金及现金等价物余额 | 1,919,996,777.92 | 957,598,800.01 | 1,223,745,115.33 | 785,040,710.5 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 172,558,089.51 | - | 270,238,470.48 |
最新报告期：2026-11-04| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 长城证券 | 刘鹏 | 0.79 | 0.95 | 1.12 | 2026-11-04 |
| 西南证券 | 朱会振 | 0.80 | 1.03 | 1.22 | 2026-10-30 |
| 国泰海通 | 林逸丹,王艳君 | 0.80 | 1.01 | 1.14 | 2026-10-28 |
| 申万宏源 | 吕昌,王子昂 | 0.77 | 1.08 | 1.26 | 2026-10-28 |
| 浙商证券 | 钟烨晨 | 0.77 | 0.93 | 1.03 | 2026-10-27 |